Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Syngene International Ltd. ( (IN:SYNGENE) ) just unveiled an announcement.
Syngene International Limited has announced a scheduled meeting with an analyst or institutional investor, Whiteoak Capital, to be held virtually on May 6, 2025. The company has assured that no unpublished price-sensitive information will be disclosed during this meeting, and the details will be available on their website.
More about Syngene International Ltd.
Syngene International Limited is a company based in Bengaluru, India, operating within the biotechnology sector. It is known for providing contract research and manufacturing services to the pharmaceutical, biotechnology, and agrochemical industries.
YTD Price Performance: -29.77%
Average Trading Volume: 61,881
Current Market Cap: 248.3B INR
See more data about SYNGENE stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money